ASCENDIS PHARMA A/S AMERICAN D (ASND) Covered Calls

You can sell covered calls on ASCENDIS PHARMA A/S AMERICAN D to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ASND (prices last updated Tue 1:00 PM ET):

ASCENDIS PHARMA A/S AMERICAN D (ASND) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
67.50 -0.84 67.15 67.59 77K - 2.9B
Covered Calls For ASCENDIS PHARMA A/S AMERICAN D (ASND)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Aug 17 70 0.05 67.54 0.1% 9.1%
Sep 21 70 2.70 64.89 4.2% 39.3%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Ascendis Pharma A/S, a clinical stage biopharmaceutical company, develops various prodrug therapies for unmet medical needs. The company develops TransCon human growth hormone, which is in Phase III clinical study in children to treat growth hormone deficiency; TransCon parathyroid hormone that is in Phase I clinical study for treating hypoparathyroidism; and TransCon C-type natriuretic peptide for the treatment of achondroplasia. It also has strategic collaborations with Sanofi to develop TransCon Peptides for the treatment of diabetes; and Genentech and Roche to develop TransCon anti-vascular endothelial growth factor (VEGF), a compound to support injection of anti-VEGF in ophthalmology. Ascendis Pharma A/S was founded in 2006 and is headquartered in Hellerup, Denmark